- 全部删除
- 您的购物车当前为空
Tiratricol (3,3',5-Triiodothyroacetic acid) 是 T3 和 T4 甲状腺激素的代谢物;促进高脂血症、局部脂肪营养不良和肥胖。它已用于研究 Allan-Herndon-Dudley 综合征治疗的试验。
Tiratricol (3,3',5-Triiodothyroacetic acid) 是 T3 和 T4 甲状腺激素的代谢物;促进高脂血症、局部脂肪营养不良和肥胖。它已用于研究 Allan-Herndon-Dudley 综合征治疗的试验。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 mg | ¥ 116 | In stock |
Tiratricol 相关产品
产品描述 | Tiratricol (3,3',5-Triiodothyroacetic acid) is a metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome. |
体内活性 | 研究表明,Tiratricol可使甲状腺肿减少,对皮质类固醇激素使用降低引起的萎缩也有一定效果。Tiratricol可治疗甲状腺激素抵抗综合征,结合甲状腺素抑制甲状腺癌患者体内促甲状腺激素的产生。 |
别名 | 替拉曲可, 3,3',5-Triiodothyroacetic acid |
分子量 | 621.93 |
分子式 | C14H9I3O4 |
CAS No. | 51-24-1 |
Smiles | O(C1=C(I)C=C(CC(O)=O)C=C1I)C2=CC(I)=C(O)C=C2 |
密度 | 2.466 g/cm3 |
存储 | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble), The compound is unstable in solution. Please use soon. DMSO: 93 mg/mL (149.53 mM), Sonication is recommended. The compound is unstable in solution. Please use soon. Ethanol: 93 mg/mL (149.53 mM), Sonication is recommended. The compound is unstable in solution. Please use soon. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容